| RS41529049 |
IL17RA
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 51, Immunodeficiency 51 |
| RS41529445 |
MMP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Metaphyseal anadysplasia 2, Metaphyseal anadysplasia 2 |
| RS41529844 |
HBA2
|
Health Risk |
Conflicting classifications of pathogenicity |
HEMOGLOBIN SUN PRAIRIE, Erythrocytosis |
| RS41530750 |
HBA1
|
Health Risk |
Conflicting classifications of pathogenicity |
HEMOGLOBIN HEKINAN, HEMOGLOBIN HEKINAN |
| RS41542214 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome |
| RS41545019 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, MSH3-related disorder |
| RS41546712 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, POLG-related disorder |
| RS41548013 |
POLA1
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked reticulate pigmentary disorder, X-linked reticulate pigmentary disorder |
| RS41550117 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Hereditary spastic paraplegia |
| RS41552412 |
ERCC4
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group F |
| RS41554817 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS41555416 |
RECQL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Baller-Gerold syndrome, Hereditary cancer-predisposing syndrome |
| RS41555714 |
MLH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Endometrial carcinoma, Colorectal cancer |
| RS41556519 |
ERCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Xeroderma pigmentosum, group D |
| RS41557217 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome 5 |
| RS41562713 |
ERCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebrooculofacioskeletal syndrome 1, Age related macular degeneration 5 |
| RS41562717 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Ovarian serous cystadenocarcinoma, Clear cell carcinoma of kidney |
| RS41563714 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Colorectal cancer |
| RS42034 |
CDK6
|
Health Risk |
association |
Behcet disease, Behcet disease |
| RS421016 |
GBA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Gaucher disease type II, Gaucher disease type I |
| RS4240659 |
RP1L1
|
Health Risk |
Conflicting classifications of pathogenicity |
Occult macular dystrophy, Retinitis pigmentosa 88 |
| RS4241211 |
SLC9A4
|
Health Risk |
association |
Ascending aortic dissection, Ascending aortic dissection |
| RS42490 |
RIPK2
|
Health Risk |
Uncertain risk allele |
Leprosy, susceptibility to |
| RS4252041 |
IL1RN
|
Health Risk |
Conflicting classifications of pathogenicity |
Sterile multifocal osteomyelitis with periostitis and pustulosis, Autoinflammatory syndrome |
| RS4252187 |
PLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Otitis media, susceptibility to |
| RS4253006 |
ERCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1 |
| RS4253012 |
ERCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS4253046 |
ERCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2 |
| RS4253196 |
ERCC6
|
Health Risk |
Pathogenic/Likely pathogenic |
Cockayne syndrome type 2, Cerebrooculofacioskeletal syndrome 1 |
| RS4253208 |
ERCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
Cockayne syndrome type 2, Cerebrooculofacioskeletal syndrome 1 |
| RS4253228 |
ERCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS4253373 |
KLKB1
|
Health Risk |
Conflicting classifications of pathogenicity |
KLKB1-related disorder, KLKB1-related disorder |
| RS4253426 |
F11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary factor XI deficiency disease, Plasma factor XI deficiency |
| RS4267009 |
ABCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dubin-Johnson syndrome, ABCC2-related disorder |
| RS4289320 |
ATP2C1
|
Health Risk |
Pathogenic |
— |
| RS429358 |
APOE
|
Health Risk |
Conflicting classifications of pathogenicity; other; risk factor |
Alzheimer disease 2, Alzheimer disease |
| RS4316537 |
DHCR7
|
Health Risk |
Conflicting classifications of pathogenicity |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS431825170 |
ADAMTS10
|
Health Risk |
Pathogenic |
Weill-Marchesani syndrome 1, Weill-Marchesani syndrome 1 |
| RS431825171 |
LZTFL1
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 17, Bardet-Biedl syndrome 17 |
| RS431825277 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825278 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825280 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825281 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825282 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825284 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825285 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825286 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825287 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825288 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825290 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825291 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825292 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825293 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825294 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825295 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825296 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825297 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825298 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS431825299 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825300 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825301 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825302 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825303 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825304 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825305 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825306 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825307 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825308 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825309 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825310 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825311 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825315 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825316 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825317 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825318 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825319 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825320 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825321 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825322 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825323 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825324 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825325 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825328 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825329 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825330 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825332 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825333 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825334 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825335 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825336 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825337 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825338 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825339 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825342 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825343 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825344 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825345 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825346 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825347 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825350 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |